BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/18/2026 9:51:21 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-30 01:42 |
|
Peer-Review Started |
|
2026-01-30 01:42 |
|
First Decision by Editorial Office Director |
|
2026-02-06 10:14 |
|
Return for Revision |
|
2026-02-06 10:14 |
|
Revised |
|
2026-02-19 22:39 |
|
Publication Fee Transferred |
|
2026-03-01 21:26 |
|
Second Decision by Editor |
|
2026-05-06 03:18 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-06 08:48 |
|
Articles in Press |
|
2026-05-06 08:48 |
|
Edit the Manuscript by Language Editor |
|
2026-05-18 04:16 |
|
Typeset the Manuscript |
|
2026-06-10 01:57 |
|
Publish the Manuscript Online |
|
2026-06-18 09:51 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Respiratory System |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Cardiovascular outcomes of sodium-glucose co-transporter-2 inhibitors in heart failure and coexisting chronic obstructive pulmonary disease: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zaraq Ahmad Khan, Rohab Sohail, Ridda Khattak, Vyom Patel, Marcos Alberto Jr, Prakhar Anand, Andrei Feldiorean, Mark Georgy, Lindsey Marie Valdiviez, David Poldneff, Zoraiz Khan, Ibraheem Murtaza and Shawn Curry |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zaraq Ahmad Khan, Department of Internal Medicine, Indiana University School of Medicine Southwest, 520 S 7th Street, Vincennes, IN 47591, United States. zaraqakhan@gmail.com |
| Key Words |
Chronic obstructive pulmonary disease; Heart failure; Sodium-glucose co-transporter-2 inhibitors; Sodium-glucose co-transporter-2; Cardioprotective; Dapagliflozin; Empagliflozin |
| Core Tip |
This meta-analysis evaluates the safety and efficacy of sodium-glucose co-transporter-2 inhibitors (SGLT-2I) in patients with congestive heart failure (HF) and coexisting chronic obstructive pulmonary disease, a population underrepresented in major HF trials. Across four randomized controlled trials, SGLT-2I significantly reduced HF hospitalizations and time-to-first hospitalization without increasing adverse events, while no mortality benefit was observed. These findings support the safe use of SGLT-2I to reduce hospitalization burden in this high-risk comorbid population. |
| Publish Date |
2026-06-18 09:51 |
| Citation |
Khan ZA, Sohail R, Khattak R, Patel V, Alberto Jr M, Anand P, Feldiorean A, Georgy M, Valdiviez LM, Poldneff D, Khan Z, Murtaza I, Curry S. Cardiovascular outcomes of sodium-glucose co-transporter-2 inhibitors in heart failure and coexisting chronic obstructive pulmonary disease: A meta-analysis. World J Cardiol 2026; 18(6): 119509
|
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i6/119509.htm |
| DOI |
https://doi.org/10.4330/wjc.119509 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
